Related Experiment Video
Updated: Feb 3, 2026

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
Published on: January 12, 2019
Clinical Characteristics of Infective Endocarditis in Children
Jelte Kelchtermans1, Lorenz Grossar1, Benedicte Eyskens1
1From the Pediatric Cardiology, Department of Cardiovascular Developmental Biology, KU Leuven, Belgium.
Insights
Pediatric infective endocarditis (IE) shows a shift towards community-acquired cases, primarily caused by streptococci and staphylococci. Awareness and prevention are vital, especially for children with prosthetic grafts.
Area of Science:
- Pediatric Cardiology
- Infectious Diseases
- Cardiovascular Surgery
Background:
- Infective endocarditis (IE) presents significant diagnostic and therapeutic challenges in children, often leading to high morbidity and mortality.
- Congenital heart defects are a major predisposing factor in pediatric IE cases.
Purpose of the Study:
- To evaluate the microbial profile and clinical manifestations of infective endocarditis (IE) in a pediatric population.
- To identify trends in community-acquired versus hospital-acquired IE in children over time.
Main Methods:
- Retrospective study of pediatric IE cases treated between 2000 and 2017.
- Review of clinical presentation, treatment, complications, outcomes, causative microorganisms, and congenital heart defects.
Main Results:
- Fifty-three pediatric IE cases were analyzed; 36% required cardiac surgery, and 13% died.
- Viridans group streptococci (32%), Staphylococcus aureus (25%), and coagulase-negative staphylococci (20%) were the most common causative organisms.
- A significant increase in community-acquired IE was observed from 2000-2007 to 2008-2017, with coagulase-negative staphylococci prevalent in hospital-acquired cases.
Conclusions:
- Pediatric IE incidence remained stable, but a shift towards community-acquired infections occurred.
- Streptococci and staphylococci remain the predominant pathogens in pediatric IE.
- Emphasizes the critical need for IE awareness and prevention strategies, particularly in pediatric patients with prosthetic grafts.
Background:
Infective endocarditis (IE) remains a diagnostic and therapeutic challenge associated with high morbidity and mortality. We evaluated the microbial profile and clinical manifestation of IE in children.
Methods:
A retrospective study examining pediatric IE cases treated between 2000 and 2017 at the Department of Pediatric Cardiology, KU Leuven, was conducted. Clinical presentation, treatment, complications, outcome of IE, underlying microorganisms and congenital heart defects were reviewed.
Results:
Fifty-three patients were diagnosed with IE. Overall, 19 patients (36%) required cardiac surgery. Seven patients (13%) died. Eighty-seven percent of patients had an underlying congenital cardiac defect. Eighteen (34%) children presented with prosthetic graft IE. A causative organism was found in 49 (92%) cases: viridans group streptococci were identified in 17 (32%), Staphylococcus aureus in 13 (25%) and coagulase-negative staphylococci in 11 (20%) children. Community-acquired (CA) IE increased significantly from 8 (33%) cases in 2000-2007 to 20 (74%) cases in 2008-2017 (P < 0.01). Even with viridans streptococci being significantly more prevalent in the CA group (P < 0.01), we did not observe an increase of streptococcal IE from 2008 to 2017. Seventeen (32%) patients presented with hospital-acquired IE during the first year of life with 14 (82%) children after surgery and a prevalence of coagulase-negative staphylococci (53%).
Conclusions:
The incidence of pediatric IE was similar over the investigated time period with a shift toward CA IE. Streptococci and staphylococci accounted for the majority of cases in both periods. Awareness of IE and its prevention is crucial in patients after implantation of prosthetic grafts.
Related Concept Videos
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis I: Introduction
Characteristics of Life
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Characteristics of Fluids

